
Sign up to save your podcasts
Or


Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner.
18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation. Ulaner et al. Radiology 2022; 305:419–428.
By The Radiological Society of North America4.7
8888 ratings
Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner.
18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation. Ulaner et al. Radiology 2022; 305:419–428.

30,609 Listeners

11,099 Listeners

7,913 Listeners

4,225 Listeners

1,067 Listeners

504 Listeners

2,455 Listeners

113,121 Listeners

16,169 Listeners

28 Listeners

45 Listeners

6,097 Listeners

209 Listeners

13 Listeners

40 Listeners